Literature DB >> 24063437

Primary signet ring cell carcinoma of the eyelid.

Jennifer S L Tan1, Penelope A McKelvie, Thomas G Hardy.   

Abstract

Primary signet ring cell carcinoma of the eyelid (PSCE) is a very rare tumour. Only a few cases having been reported to date. The majority of patients have been middle-age to elderly men. Different treatment modalities have been applied in cases of PSCE. Here, we report a case of PSCE in a man treated with orbital exenteration and radiotherapy.

Entities:  

Mesh：

Year:  2013        PMID： 24063437     DOI： 10.3109/01676830.2013.833254

Source DB:  PubMed          Journal:  Orbit        ISSN： 0167-6830


  4 in total

1.  Primary Eccrine Adenocarcinoma: A Rare but Dangerous Lesion of the Eyelid.

Authors:  John Awad; David Cheung
Journal:  J Clin Aesthet Dermatol       Date:  2021-04-01

2.  Sclerosing Signet Ring Cell Carcinoma of the Lacrimal Gland: A Potentially New Primary Entity.

Authors:  Frederick A Jakobiec; Edith R Reshef; Lina Ma; Martin K Selig; Daniel R Lefebvre; Anna M Stagner
Journal:  Ocul Oncol Pathol       Date:  2020-02-07

3.  Diagnostic and treatment challenges of a case of primary cutaneous signet-ring cell/histiocytoid carcinoma of the eyelid.

Authors:  Mathew M Palakkamanil; Muhammad N Mahmood; Audrey Chan
Journal:  BMC Ophthalmol       Date:  2020-10-14       Impact factor: 2.209

4.  Primary Signet Ring Cell/Histiocytoid Carcinoma of the Eyelid: Somatic Mutations in CDH1 and Other Clinically Actionable Mutations Imply Early Use of Targeted Agents.

Authors:  Lei-Chi Wang; Tai-Chi Lin; Yi-Chen Yeh; Hsiang-Ling Ho; Chieh-Chih Tsai; Teh-Ying Chou
Journal:  Curr Oncol       Date:  2021-02-16       Impact factor: 3.677
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.